Tranexamic Acid 100mg | 10mL Injectable SDV
ARM-72485051010
Armas Pharmaceuticals
-
RX License on File Required to Order
Detail
Blood Clots Treatment
Product Overview:
Tranexamic Acid Injection, manufactured by Armas Pharmaceuticals, is a versatile antifibrinolytic agent designed to reduce or prevent excessive bleeding in a variety of medical settings. This injectable formulation is supplied as a 100 mg/mL concentration in a 10 mL single-dose vial, offering precision in dosage and ease of use.
Indications:
Tranexamic Acid is commonly used for the treatment and prevention of hemorrhage in:
- Surgical Procedures: To reduce blood loss during and after surgery, including cardiac, orthopedic, gynecological, and dental surgeries.
- Trauma: To control acute bleeding following trauma, as part of massive transfusion protocols.
- Menorrhagia: To manage heavy menstrual bleeding in applicable cases.
- Postpartum Hemorrhage: To aid in reducing life-threatening postpartum bleeding when other measures are insufficient.
- Hereditary Angioedema: As adjunctive therapy to prevent episodes of swelling or airway obstruction.
Key Features & Benefits:
- High Potency: The 100 mg/mL concentration ensures effective fibrinolysis inhibition for hemostatic stability.
- Single-Dose Vial: Facilitates sterile and accurate administration without the risk of cross-contamination.
- Rapid Onset: Quickly achieves desired therapeutic effects, especially crucial in emergency or perioperative settings.
- Versatility: Effective across a broad spectrum of bleeding-related conditions and surgical specialties.
- Stability: Formulated to meet high standards of purity and consistency, ensuring safety and efficacy.